Cochrane Abstracts
Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia Edited (no change to conclusions)
Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Naloxone for Preventing Morbidity and Mortality in Newborn Infants of Greater Than 34 Weeks' Gestation With Suspected Perinatal Asphyxia Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433624/all/Naloxone_for_preventing_morbidity_and_mortality_in_newborn_infants_of_greater_than_34_weeks'_gestation_with_suspected_perinatal_asphyxia:_Cochrane_systematic_review. Accessed 01 July 2022.
Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433624/all/Naloxone_for_preventing_morbidity_and_mortality_in_newborn_infants_of_greater_than_34_weeks'_gestation_with_suspected_perinatal_asphyxia:_Cochrane_systematic_review. Accessed July 1, 2022.
Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433624/all/Naloxone_for_preventing_morbidity_and_mortality_in_newborn_infants_of_greater_than_34_weeks'_gestation_with_suspected_perinatal_asphyxia:_Cochrane_systematic_review
Naloxone for Preventing Morbidity and Mortality in Newborn Infants of Greater Than 34 Weeks' Gestation With Suspected Perinatal Asphyxia Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2022 July 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433624/all/Naloxone_for_preventing_morbidity_and_mortality_in_newborn_infants_of_greater_than_34_weeks'_gestation_with_suspected_perinatal_asphyxia:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Naloxone for preventing morbidity and mortality in newborn infants of greater than 34 weeks' gestation with suspected perinatal asphyxia Edited (no change to conclusions)
ID - 433624
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433624/all/Naloxone_for_preventing_morbidity_and_mortality_in_newborn_infants_of_greater_than_34_weeks'_gestation_with_suspected_perinatal_asphyxia:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
